LAPIS

What is LAPIS?

Lapis is a next-generation nanoformulation platform based on layer-by-layer (LbL) submicroparticle technology. This modular and customizable system enables the precise delivery of a wide range of therapeutic agents, including mRNA, DNA, proteins, and small molecules, tailored to diverse biomedical applications.
 

 Our Technology

LAPIS is built on a modular architecture, allowing each layer to be functionalized with specific components such as small molecules, targeting ligands, or adjuvants. This flexibility enables the creation of targeted, efficient, and application-specific delivery systems.
 

Key features

Key findings

 What we offer

Who we are 

The Aerts Lab, established in 2015, has pioneered research in mRNA-based therapeutic vaccines for HIV and cancer. In 2023, we launched LAPIS to enhance the performance of LbL submicroparticles. A patent application (WO2025 051807 A1) for LAPIS has recently been published, marking a significant milestone in our translational journey.